Literature DB >> 16336583

Tubulointerstitial damage and progression of renal failure.

Bernardo Rodríguez-Iturbe1, Richard J Johnson, Jaime Herrera-Acosta.   

Abstract

The present work reviews the mechanisms and close association between glomerular and tubular damage and its relationship to renal functional impairment. In addition, we present an overview of the pathways involved in the progression of tubulointerstitial fibrosis and a brief summary of the treatments used to retard the progression to end-stage renal failure.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16336583     DOI： 10.1111/j.1523-1755.2005.09915.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN： 0098-6577            Impact factor:   10.545


  48 in total

Review 1.  The pathobiology of diabetic vascular complications--cardiovascular and kidney disease.

Authors:  Stephen P Gray; Karin Jandeleit-Dahm
Journal:  J Mol Med (Berl)       Date:  2014-04-01       Impact factor: 4.599

2.  Clinical significance of fractional magnesium excretion (FEMg) as a predictor of interstitial nephropathy and its correlation with conventional parameters.

Authors:  Chie Noiri; Taisuke Shimizu; Kaori Takayanagi; Yosuke Tayama; Takatsugu Iwashita; Shimpei Okazaki; Minoru Hatano; Osamu Matsumura; Hitoshi Kato; Akihiko Matsuda; Tetsuya Mitarai; Hajime Hasegawa
Journal:  Clin Exp Nephrol       Date:  2015-02-28       Impact factor: 2.801

3.  Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure.

Authors:  T Nakamura; T Sugaya; H Koide
Journal:  Diabetologia       Date:  2006-12-15       Impact factor: 10.122

4.  Galectin-3 and new-onset CKD: marker or mediator?

Authors:  Pietro Ravani; Brendan J Barrett
Journal:  J Am Soc Nephrol       Date:  2013-06-20       Impact factor: 10.121

5.  Role of protein kinase C in advanced glycation end products-induced epithelial-mesenchymal transition in renal proximal tubular epithelial cells.

Authors:  Shuwang Ge; Rui Zeng; Yun Luo; Lin Liu; Honglan Wei; Juan Zhang; Huan Zhou; Gang Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

6.  Downregulation of microRNA-429 contributes to angiotensin II-induced profibrotic effect in rat kidney.

Authors:  Zhengchao Wang; Qing Zhu; Weili Wang; Junping Hu; Pin-Lan Li; Fan Yi; Ningjun Li
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-22

7.  Tubulointerstitial fibrosis can sensitize the kidney to subsequent glomerular injury.

Authors:  Beom Jin Lim; Jae Won Yang; Jun Zou; Jianyong Zhong; Taiji Matsusaka; Ira Pastan; Ming-Zhi Zhang; Raymond C Harris; Hai-Chun Yang; Agnes B Fogo
Journal:  Kidney Int       Date:  2017-07-12       Impact factor: 10.612

8.  Farnesoid X Receptor Agonism Protects against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic Nephropathy.

Authors:  Andi Marquardt; Moh'd Mohanad Al-Dabet; Sanchita Ghosh; Shrey Kohli; Jayakumar Manoharan; Ahmed ElWakiel; Ihsan Gadi; Fabian Bock; Sumra Nazir; Hongjie Wang; Jonathan A Lindquist; Peter Paul Nawroth; Thati Madhusudhan; Peter R Mertens; Khurrum Shahzad; Berend Isermann
Journal:  J Am Soc Nephrol       Date:  2017-07-10       Impact factor: 10.121

9.  Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts.

Authors:  Hanni Menn-Josephy; Carol S Lee; Angela Nolin; Marta Christov; Denis V Rybin; Janice M Weinberg; Joel Henderson; Ramon Bonegio; Andrea Havasi
Journal:  Am J Nephrol       Date:  2016-09-15       Impact factor: 3.754

Review 10.  Can we target tubular damage to prevent renal function decline in diabetes?

Authors:  Joseph V Bonventre
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.